Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.198%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

17 Apr 2018 07:00

RNS Number : 0923L
Ashmore Group PLC
17 April 2018
 

Ashmore Group plc+0700 17 April 2018

THIRD QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 31 March 2018.

Assets under management

Theme

Actual31 December 2017

(US$ billion)

Estimated31 March 2018

(US$ billion)

Movement pre-reclassification1

(%)

External debt

15.0

15.3

+1%

Local currency

14.9

17.7

+19%

Corporate debt

7.8

9.4

+21%

Blended debt

18.8

20.7

+11%

Equities

3.9

4.3

+10%

Alternatives

1.6

1.5

-6%

Multi-asset

1.2

1.2

-

Overlay / liquidity

6.3

6.4

+2%

Total

69.5

76.5

+10%

 

Assets under management increased by US$7.0 billion during the period, with net inflows of US$6.4 billion and positive investment performance of US$0.6 billion.

Continued investor demand for Emerging Markets assets delivered net inflows in each of the fixed income and equities investment themes during the quarter, resulting in the strongest quarter for gross and net flows since June 2013. The flows continued to be broad-based by investor type, including significant top-ups from a range of clients. Net flows were strongest in the local currency, blended debt and corporate debt themes, and also positive in equities, external debt and overlay/liquidity.

Ashmore's active investment processes delivered positive investment performance despite more volatile market conditions, particularly in February. Local currency and blended debt portfolios delivered strong levels of absolute and relative performance while the US dollar-denominated external debt and corporate debt themes performed in line with slightly lower market levels. Performance in the equities theme was marginally negative overall but with continued outperformance in the specialist products such as frontier markets.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

 "This quarter has seen particularly strong net inflows across the range of the Group's products. Over the medium to longer term, positive investor sentiment towards Emerging Markets will continue to be supported by attractive valuations, the need for institutional investors to address underweight allocations, better earnings and credit fundamentals, and relative currency strength arising from further US dollar weakness.

"Significantly, the increased market volatility experienced over the past three months has had little effect on the fundamental drivers of returns in Emerging Markets and, as expected, both Emerging Markets fixed income and equity markets have outperformed. Volatility that originates in the developed world typically leads to Emerging Markets assets being mispriced, presenting attractive investment opportunities for Ashmore with its specialist, active management approach and a focus on value."

 

Notes

1. During the quarter, assets totalling US$0.2 billion were reclassified from blended debt to external debt as a result of changes to benchmarks and investment guidelines. Including the reclassification, external debt AuM increased by 2% and blended debt AuM increased by 10% over the three months.

 

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingAndrew Walton +44 (0)20 3727 1514Laura Ewart +44 (0)20 3727 1160

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDSSIRLIT
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.